Insider Trading: Dendreon Corp (DNDN.O)

DNDN.O on Nasdaq

2.65USD
17 Apr 2014
Price Change (% chg)

$-0.04 (-1.49%)
Prev Close
$2.69
Open
$2.69
Day's High
$2.73
Day's Low
$2.62
Volume
2,183,472
Avg. Vol
3,415,265
52-wk High
$5.38
52-wk Low
$2.23

Search Stocks
POULTON ROBERT S
Trading Date Type Shares Traded Price Shares Held
2 Jan 2013 Sell 8,598 $5.79 112,957
29 Nov 2012 Sell 460 $4.45 121,555
30 Aug 2012 Sell 462 $4.49 122,015
30 May 2012 Sell 432 $6.75 122,477

Institutional Holders

% Shares Owned: 40.26%
# of Holders: 167
Total Shares Held: 64,003,002
3 Mo. Net Change: -98,375
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 8
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

John Johnson

2012 Chairman of the Board, President, Chief Executive Officer

Gregory Cox

47 2013 Interim Chief Financial Officer, Principal Accounting Officer

Gregory Mayes

44 2013 Executive Vice President - Human Resources

William Monteith

55 2013 Executive Vice President - Technical Operations

Lindsay Rocco

34 2012 Executive Vice President - Corporate Communications

Andrew Sandler

2014 Executive Vice President, Chief Medical Officer

Robert Crotty

2014 Interim General Counsel, Interim Secretary

Douglas Watson

68 2012 Lead Independent Director

David Urdal

63 2011 Director

Susan Bayh

53 2003 Independent Director

Bogdan Dziurzynski

64 2001 Independent Director

Dennis Fenton

61 2011 Independent Director

David Stump

64 2010 Independent Director
Search Stocks